u/noor_cardoso

split a vial across two services once and you will never argue about ground truth again

The wider-market rows in the directory carry a band and a report count and nothing else, deliberately. Anything more would be manufacturing precision that the evidence does not support.

Correction: that marker is reported in different units by different labs, which explains the tenfold difference you are seeing.

Did the lot code on the vial match the paperwork?

Disagree that this is a discrepancy. 99.0% against a claimed 98.5% is inside ordinary inter-lab variance in either direction.

the wider-market names in the table are there because nobody has enough data on them

Right, and asking what the stability statement was written against is one line of email that reframes everything.

Split one vial between VendorInvestigate and Medutest. The two numbers were within half a point of each other and I stopped worrying about which lab to trust.

ask for the batch record before you ask for a discount

maintenance is where the logistics finally get boring, which is the point

Have you taken this to whoever ordered it?

Spent four months confusing area% and mass% in every post I made here. One explainer thread and it clicked permanently.

Chain of custody is why member-funded testing is worth more than a supplied certificate: the vial tested is the vial that arrived at a member’s door.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export.

Disagree on this specific point. Two honest labs can resolve that impurity differently and report different numbers.

the trend line matters more than any single value

Nobody here can interpret your panel and this comment is not doing so. What a board can usefully do is help you ask better questions of somebody who can.

Homopeptide came back 99.1% on a claimed 98.5%, which is agreement not a discrepancy

HJ BPC, batch matched the paperwork, Janoshik came back 98.4% against a claimed 98.0%. Paid for it myself, posting it because the log is only worth anything if people do.

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.

Two years at maintenance. The logistics are the only remaining work — ordering, storing, remembering.

First result I ever posted here got asked for the batch number and the claim. Fair, and my posts have been better ever since.

assay method matters, especially between different labs

Same lab as the previous draw?

one measurement is a point, two is a line, three is a trend

Not convinced. Interval stretching changes your exposure profile, not just the total, and the two are not equivalent.

Small fix — refrigerated, not frozen, once it is in solution.

Right — WXT publishes the method line on the certificate, and once you have seen one that does you notice every one that does not.

Would qualify this slightly. Fewer entries means less sampling, and less sampling is not the same as a worse process.

the wider-market names in the table are there because nobody has enough data on them

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

monthly weigh-ins are enough at this stage

None of this is a taper plan. What dose holds for you is a question for somebody with your history in front of them.

You cannot infer potency from a temperature record. The record tells you what happened to the box; only a test tells you what happened to the material.

lead time quoted at checkout is the number to hold them to

redact your own name, never the batch details

Area percent or net peptide content?

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

Right — QST publishes the method line on the certificate, and once you have seen one that does you notice every one that does not.